Chemomab Therapeutics Stock Forecast - Accumulation Distribution
| CMMB Stock | USD 1.71 0.01 0.58% |
Chemomab Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Chemomab Therapeutics stock prices and determine the direction of Chemomab Therapeutics Ltd's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Chemomab Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time the rsi of Chemomab Therapeutics' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Chemomab Therapeutics hype-based prediction, you can estimate the value of Chemomab Therapeutics Ltd from the perspective of Chemomab Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Chemomab Therapeutics after-hype prediction price | USD 1.71 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Chemomab Therapeutics to cross-verify your projections. Chemomab Therapeutics Additional Predictive Modules
Most predictive techniques to examine Chemomab price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Chemomab using various technical indicators. When you analyze Chemomab charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 8027.03 | 0.0919 |
| Check Chemomab Therapeutics Volatility | Backtest Chemomab Therapeutics | Information Ratio |
Chemomab Therapeutics Trading Date Momentum
| On January 23 2026 Chemomab Therapeutics Ltd was traded for 1.71 at the closing time. The top price for the day was 1.85 and the lowest listed price was 1.68 . There was no trading activity during the period 0.0. Lack of trading volume on January 23, 2026 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Chemomab Therapeutics to competition |
Other Forecasting Options for Chemomab Therapeutics
For every potential investor in Chemomab, whether a beginner or expert, Chemomab Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Chemomab Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Chemomab. Basic forecasting techniques help filter out the noise by identifying Chemomab Therapeutics' price trends.Chemomab Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Chemomab Therapeutics stock to make a market-neutral strategy. Peer analysis of Chemomab Therapeutics could also be used in its relative valuation, which is a method of valuing Chemomab Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Chemomab Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Chemomab Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Chemomab Therapeutics shares will generate the highest return on investment. By undertsting and applying Chemomab Therapeutics stock market strength indicators, traders can identify Chemomab Therapeutics Ltd entry and exit signals to maximize returns.
Chemomab Therapeutics Risk Indicators
The analysis of Chemomab Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Chemomab Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting chemomab stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.25 | |||
| Standard Deviation | 4.2 | |||
| Variance | 17.65 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Chemomab Therapeutics
The number of cover stories for Chemomab Therapeutics depends on current market conditions and Chemomab Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Chemomab Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Chemomab Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Chemomab Therapeutics Short Properties
Chemomab Therapeutics' future price predictability will typically decrease when Chemomab Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Chemomab Therapeutics Ltd often depends not only on the future outlook of the potential Chemomab Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Chemomab Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 4.5 M | |
| Cash And Short Term Investments | 14.3 M |
Check out Historical Fundamental Analysis of Chemomab Therapeutics to cross-verify your projections. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemomab Therapeutics. If investors know Chemomab will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemomab Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Chemomab Therapeutics is measured differently than its book value, which is the value of Chemomab that is recorded on the company's balance sheet. Investors also form their own opinion of Chemomab Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Chemomab Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemomab Therapeutics' market value can be influenced by many factors that don't directly affect Chemomab Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemomab Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemomab Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemomab Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.